| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/S10067-007-0806-8 |
| P8608 | Fatcat ID | release_3a6ihkmmfbel3itnbtkgng643i |
| P698 | PubMed publication ID | 18066611 |
| P2093 | author name string | Kosmas I Paraskevas | |
| P2860 | cites work | Depressive symptoms in early rheumatoid arthritis: a comparative longitudinal study | Q79858068 |
| Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis | Q80843926 | ||
| Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors | Q81300622 | ||
| When is a patient with rheumatoid arthritis at risk for cardiovascular disease? | Q82500246 | ||
| Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA | Q83007682 | ||
| Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 | ||
| Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis | Q24679573 | ||
| Withdrawal of cerivastatin from the world market | Q24806904 | ||
| Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study | Q24812262 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion | Q28217906 | ||
| MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction | Q28581447 | ||
| Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
| The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells | Q32060189 | ||
| Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women | Q34067367 | ||
| Rheumatology and musculoskeletal medicine | Q34098905 | ||
| Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 | ||
| Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial | Q34327988 | ||
| The mortality of rheumatoid arthritis | Q34338843 | ||
| Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? | Q34601733 | ||
| Innate and acquired immunity in atherogenesis | Q34986341 | ||
| Unraveling pleiotropic effects of statins on plaque rupture | Q34993911 | ||
| Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. | Q35553700 | ||
| Endothelial expression of MHC class II molecules in autoimmune disease | Q35644284 | ||
| Current overview of statin-induced myopathy | Q35684789 | ||
| Autoimmune and inflammatory mechanisms in atherosclerosis | Q35698466 | ||
| Measuring quality of life in rheumatic conditions | Q35741141 | ||
| Detection of activated T lymphocytes in the human atherosclerotic plaque | Q35817589 | ||
| Do statins offer therapeutic potential in inflammatory arthritis? | Q35952218 | ||
| The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway | Q35994778 | ||
| Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. | Q36031031 | ||
| Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention | Q36101597 | ||
| Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions | Q36101622 | ||
| Statin therapy in rheumatoid arthritis | Q36162206 | ||
| Atherosclerosis in patients with autoimmune disorders | Q36173656 | ||
| Successfully living with chronic arthritis. The role of the allied health professionals. | Q36190488 | ||
| Rheumatoid arthritis: a disease associated with accelerated atherogenesis | Q36220303 | ||
| Statins as antiinflammatory and immunomodulatory agents: a future in rheumatologic therapy? | Q36382202 | ||
| The burden of musculoskeletal disease--a global perspective | Q36446201 | ||
| Disruption of TGF-β signaling in T cells accelerates atherosclerosis | Q36524547 | ||
| Mechanisms of disease: atherosclerosis in autoimmune diseases | Q36577423 | ||
| Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis | Q36577503 | ||
| Immunomodulatory effects of statins and autoimmune rheumatic diseases: novel intracellular mechanism involved | Q36628912 | ||
| Atherosclerosis and inflammation: insights from rheumatoid arthritis | Q36726386 | ||
| Clustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins. | Q36785148 | ||
| Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. | Q39808657 | ||
| Therapy with statins in patients with refractory rheumatic diseases: a preliminary study | Q40551294 | ||
| C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study | Q40828366 | ||
| Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors | Q43633980 | ||
| Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. | Q44068950 | ||
| Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis | Q44137425 | ||
| Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians | Q44170460 | ||
| Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events | Q44216708 | ||
| Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA. | Q44242749 | ||
| Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis | Q44652560 | ||
| All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. | Q44724213 | ||
| Statins in rheumatoid arthritis--two birds with one stone? | Q44945175 | ||
| Decreased binding of annexin v to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus. | Q45147984 | ||
| Simvastatin improves endothelial function in patients with rheumatoid arthritis | Q45244385 | ||
| Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis. | Q46787385 | ||
| Potential antiinflammatory and immunomodulatory effects of statins in rheumatologic therapy | Q46919816 | ||
| Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis | Q46919823 | ||
| Preclinical carotid atherosclerosis in patients with rheumatoid arthritis | Q46954458 | ||
| Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis | Q48502988 | ||
| Anxiety and depression in patients with rheumatoid arthritis. | Q50927037 | ||
| Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. | Q50969877 | ||
| Beneficial action of statins in patients with rheumatoid arthritis in a large observational cohort. | Q51756404 | ||
| Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors. | Q51801169 | ||
| The evaluation of quality of life in fibromyalgia syndrome: a comparison with rheumatoid arthritis by using SF-36 Health Survey. | Q51913922 | ||
| Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study. | Q53548272 | ||
| The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years | Q57540261 | ||
| Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines | Q60746676 | ||
| Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65 | Q68181448 | ||
| Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis | Q71878450 | ||
| Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice | Q73054106 | ||
| Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I | Q77296598 | ||
| High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 | ||
| Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function | Q78794847 | ||
| P433 | issue | 3 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 281-287 | |
| P577 | publication date | 2007-12-08 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Statin treatment for rheumatoid arthritis: a promising novel indication | |
| P478 | volume | 27 |
| Q37728928 | A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis |
| Q37055519 | Altered protein prenylation in Sertoli cells is associated with adult infertility resulting from childhood mumps infection |
| Q34776189 | Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis |
| Q37464427 | Breaking old paradigms: Th17 cells in autoimmune arthritis |
| Q37829385 | Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: a suggested model of preventive strategy |
| Q26744334 | Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps |
| Q47802987 | Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis |
| Q37102751 | Effect of Atorvastatin on the Disease Activity and Severity of Rheumatoid Arthritis: Double-Blind Randomized Controlled Trial |
| Q36638653 | Fibrates as therapy for osteoarthritis and rheumatoid arthritis? A systematic review |
| Q34519891 | Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice |
| Q37690217 | Hypercholesterolemia boosts joint destruction in chronic arthritis. An experimental model aggravated by foam macrophage infiltration |
| Q28388335 | Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases |
| Q48072382 | Is statin use associated with new joint-related symptoms, physical function, and quality of life? Results from two population-based cohorts of women |
| Q52784501 | Rosuvastatin promotes benefits on induced periodontitis in hypertensive rats. |
| Q37594570 | Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome |
| Q38357522 | Simvastatin inhibits TLR8 signaling in primary human monocytes and spontaneous TNF production from rheumatoid synovial membrane cultures |
| Q37691945 | Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease |
| Q42345718 | Sizing up stability: combination therapy with Apo-AI peptide mimetics and statins in systemic lupus erythematosus-mediated atherosclerosis |
| Q36984463 | Statin intake is associated with MMP-1 level in gingival crevicular fluid of patients with periodontitis |
| Q46158768 | Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes |
| Q50192090 | The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis. |
| Q34398263 | The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population. |
Search more.